Search Results - "Zwerina, J"

Refine Results
  1. 1

    Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): state of the art by Vaglio, A., Buzio, C., Zwerina, J.

    Published in Allergy (Copenhagen) (01-03-2013)
    “…Eosinophilic granulomatosis with polyangiitis (Churg–Strauss, EGPA) is a systemic small‐vessel vasculitis associated with asthma and eosinophilia. Histology of…”
    Get full text
    Journal Article
  2. 2

    The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis by Schett, G, Zwerina, J, Firestein, G

    Published in Annals of the rheumatic diseases (01-07-2008)
    “…Chronic inflammatory processes are based on a sustained and tightly regulated communication network among different cells types. This network comprises…”
    Get more information
    Journal Article
  3. 3

    Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study by Brozek, W., Reichardt, B., Zwerina, J., Dimai, H. P., Klaushofer, K., Zwettler, E.

    Published in Osteoporosis international (2016)
    “…Summary We analyzed the association of bisphosphonate therapy with mortality and hip refracture incidence among osteoporosis-related hip fracture patients in…”
    Get full text
    Journal Article
  4. 4

    Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints by Uderhardt, S, Diarra, D, Katzenbeisser, J, David, J-P, Zwerina, J, Richards, W, Kronke, G, Schett, G

    Published in Annals of the rheumatic diseases (01-03-2010)
    “…To study whether Dickkopf (DKK)-1, an inhibitor of wingless (Wnt) signalling, is involved in the fusion of sacroiliac joints. Mice transgenic for tumour…”
    Get more information
    Journal Article
  5. 5

    Novel familial mutation of LRP5 causing high bone mass: Genetic analysis, clinical presentation, and characterization of bone matrix mineralization by Roetzer, K.M., Uyanik, G., Brehm, A., Zwerina, J., Zandieh, S., Czech, T., Roschger, P., Misof, B.M., Klaushofer, K.

    Published in Bone (New York, N.Y.) (01-02-2018)
    “…The Wnt signalling pathway is a critical regulator of bone mass and quality. Several heterozygous mutations in the LRP5 gene, a Wnt co-receptor, causing high…”
    Get full text
    Journal Article
  6. 6

    CTLA-4 directly inhibits osteoclast formation by Axmann, R, Herman, S, Zaiss, M, Franz, S, Polzer, K, Zwerina, J, Herrmann, M, Smolen, J, Schett, G

    Published in Annals of the rheumatic diseases (01-11-2008)
    “…CTLA-4 is a regulator of co-stimulation and inhibits the activation of T cells through interfering with the interaction of CD80/86 on antigen-presenting cells…”
    Get more information
    Journal Article
  7. 7

    Interleukin-1 is essential for systemic inflammatory bone loss by Polzer, K, Joosten, L, Gasser, J, Distler, J H, Ruiz, G, Baum, W, Redlich, K, Bobacz, K, Smolen, J S, van den Berg, W, Schett, G, Zwerina, J

    Published in Annals of the rheumatic diseases (01-01-2010)
    “…Chronic inflammation is a major risk factor for systemic bone loss leading to osteoporotic fracture and substantial morbidity and mortality. Inflammatory…”
    Get more information
    Journal Article
  8. 8

    Bone material properties and response to teriparatide in osteoporosis due to WNT1 and PLS3 mutations by Fratzl-Zelman, Nadja, Wesseling-Perry, Katherine, Mäkitie, Riikka E., Blouin, Stéphane, Hartmann, Markus A., Zwerina, Jochen, Välimäki, Ville-Valtteri, Laine, Christine M., Välimäki, Matti J., Pereira, Renata C., Mäkitie, Outi

    Published in Bone (New York, N.Y.) (01-05-2021)
    “…Patients with osteoporosis-associated WNT1 or PLS3 mutations have unique bone histomorphometric features and osteocyte-specific hormone expression patterns. To…”
    Get full text
    Journal Article
  9. 9

    Use of proton pump inhibitors and mortality after hip fracture in a nationwide study by Brozek, W., Reichardt, B., Zwerina, J., Dimai, H. P., Klaushofer, K., Zwettler, E.

    Published in Osteoporosis international (01-05-2017)
    “…Summary We analyzed the association of proton pump inhibitors (PPIs) with mortality after osteoporosis-related hip fracture in Austria. PPIs were associated…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Hemochromatosis by Oppl, B, Zwerina, J

    Published in Zeitschrift für Rheumatologie (01-09-2015)
    “…Hereditary hemochromatosis is a frequent autosomal recessive iron storage disease in northern and western Europe. The classical clinical triad of liver…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Eotaxin-3 is involved in Churg–Strauss syndrome – a serum marker closely correlating with disease activity by Polzer, K., Karonitsch, T., Neumann, T., Eger, G., Haberler, C., Soleiman, A., Hellmich, B., Csernok, E., Distler, J., Manger, B., Redlich, K., Schett, G., Zwerina, J.

    Published in Rheumatology (Oxford, England) (01-06-2008)
    “…Objective. Churg–Strauss Syndrome (CSS) is characterized by excessive eosinophil accumulation in peripheral blood and affected tissues with development of…”
    Get full text
    Journal Article
  14. 14

    Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints by Polzer, K, Baeten, D, Soleiman, A, Distler, J, Gerlag, D M, Tak, P P, Schett, G, Zwerina, J

    Published in Annals of the rheumatic diseases (01-11-2008)
    “…To investigate the presence and regulation of lymphatic vessels in inflamed joints of mice with experimental arthritis as well as patients with rheumatoid…”
    Get more information
    Journal Article
  15. 15
  16. 16

    MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course by WOHRER, S, TROCH, M, RADERER, M, STREUBEL, B, ZWERINA, J, SKRABS, C, FORMANEK, M, HAUFF, W, HOFFMANN, M, MÜLLAUER, L, CHOTT, A

    Published in Leukemia (01-08-2007)
    “…MALT lymphoma, especially of extragastric origin, is thought to be associated with an underlying autoimmune disease (AD) in a significant proportion of…”
    Get full text
    Journal Article
  17. 17

    Gender‐ and site‐specific differences of colorectal neoplasia relate to vitamin D by Aigner, E., Stadlmayr, A., Huber‐Schönauer, U., Zwerina, J., Husar‐Memmer, E., Niederseer, D., Trauner, M., Heuberger, A., Hohla, F., Schett, G., Patsch, W., Datz, C.

    Published in Alimentary pharmacology & therapeutics (01-12-2014)
    “…Summary Background The effect of vitamin D on colorectal adenomas may vary with regard to gender, localisation and histological type of the lesion. Aim To…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20